Søgning
Søgning på udtrykket 'viral meningitis' giver 6 resultater
Dokumenter [1]
Sider [2]
Nyt fra tidsskrifterne [3]
Udgiver: Dansk Selskab for Infektionsmedicin 2018
rk
Influenza,
Meningitis og encephalitis:
Christian Brandt (tovholder), Helene Mens, Lykke Larsen, Jacob Bodilsen, Lothar Wiese, Birgitte Rønde Hansen, Hans Rudolf von Lüttchau, Henrik Nielsen (referent)
Akut bakteriel meningitis,
Viral meningitis,
Encephalitis,
Lumbalpunktur af patienter i blodfortyndende behandling,
Orthopox:
Anders Koch (tovholder), Jan Gerstoft, Gitte Kronborg, Merete Storgaard, Michael Dalager-Pedersen, Thilde Fabricius, Lothar Wiese.
.
Sted:
Auditorium A, Forskningens Hus, Aalborg Universitets Hospital, Syd, Søndre Skovvej 15, 9000 Aalborg.
Program:
Torsdag d. 19/9.
09.30-10.00 Kaffe og velkomst.
10.00-10.15 DASGIB og andre nationale samarbejder HN.
10.15-11.00 Viral meningitis. Christian Brandt.
11.00-11.10 PAUSE.
11.10-11.40 Infektiøs encephalitis (del 1). Jacob Bodilsen.
11.40-12.00 Kursister – CASE gruppe 1.
12.00-13.00 FROKOST.
13.00-13.40 Infektiøs encephalitis (del 2). Jacob Bodilsen.
Nyt fra tidsskrifterne [3]
Clinical Microbiology and Infection
6.10.2024
ids ameliorate the inflammatory response due to the release of cytokines reducing inpatient mortality and neurological morbidity in community-acquired bacterial meningitis, and are advocated by guidelines in patients with suspected bacterial meningitis. As the most common causes of meningitis and encephalitis are non-bacterial, adjunctive dexamethasone is given to a substantial proportion of viral meningitis patients while awaiting confirmatory testing such a polymerase chain reaction (PCR) or cultures (3).
Clinical Microbiology and Infection
23.08.2024
To investigate whether there is a dose-dependent association between empiric dexamethasone and outcome in viral meningitis.
Infection
4.12.2024
udy was conducted from 05/14 − 01/18. With respect to Borrelia-LTT a comparison was made between patients suffering from confirmed acute LNB and patients being affected by inflammatory neurologic diseases, defining the control group: Bell‘s palsy, viral meningitis, herpes zoster, Guillain-Barré-Syndrome and Encephalomyelitis disseminate.